Effects of Appropriate Technology for Home-based Rehabilitation in Patients With Post-stroke Physical Dysfunction
1 other identifier
interventional
72
1 country
1
Brief Summary
The goal of this clinical trial is to assess the effect of S-HRAT to improve patients' motor function and activities of daily living.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Jun 2024
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2024
CompletedFirst Posted
Study publicly available on registry
May 31, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedSeptember 23, 2024
September 1, 2024
4 months
May 25, 2024
September 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Motor Function
The motor function of the patients is measured using the Motor Assessment Scale (MAS) for stroke. MAS is methodologically simple, targeted, and easily generalizable for motor function assessment in stroke patients, as well as reliable and valid. The scale consists of nine items, each of which is scored from 0 to 6 out of 48, with the ninth item not scoring. Higher scores indicate better motor function.
baseline (T0), 8-week post-intervention (T1), and 12-week follow-up (T2).
Balance
Balance was measured using the Berg Balance Scale (BBS). The scale consists of 14 items, including sitting to standing, standing independently, walking independently, and standing to sit, and each item is scored on five functional levels: 0, 1, 2, 3, and 4. A score of 4 indicates that the action under examination can be performed normally. In contrast, a score of 0 indicates that it cannot be performed or requires significant assistance. The total possible score is 56, with higher scores indicating better balance.
baseline (T0), 8-week post-intervention (T1), and 12-week follow-up (T2).
Secondary Outcomes (4)
Activity of Daily Living
baseline (T0), 8-week post-intervention (T1), and 12-week follow-up (T2).
Exercise Adherence
baseline (T0), 8-week post-intervention (T1), and 12-week follow-up (T2).
Patient Satisfaction
baseline (T0), 8-week post-intervention (T1), and 12-week follow-up (T2).
Anxiety and Depression
baseline (T0), 8-week post-intervention (T1), and 12-week follow-up (T2).
Study Arms (2)
intervention group
EXPERIMENTALHome-based rehabilitation appropriate technology (S-HRAT) training
control group
NO INTERVENTIONRoutine discharge instructions
Interventions
The S-HRAT training instruction consists of two phases: in-hospital training and post-discharge remote home training. Based on the S-HRAT list, we select individualized home rehabilitation training exercises for the participants and conduct five offline training instruction sessions one week before discharge to ensure that the participants master the correct method for each exercise and clarify precautions. At discharge, participants will receive an S-HRAT brochures, which will include detailed text, pictures and video demonstrations of exercises, to visualize the rehabilitation instructions and make them easy to understand. Participants learn how to use the S-HRAT booklet and follow a daily training program to complete the prescribed content. They will be asked to record a video of their training and send it to the researcher via WeChat for monitoring purposes and feedback.
Eligibility Criteria
You may qualify if:
- Age≥18;
- Patients diagnosed with cerebrovascular disease who have cerebral infarction or cerebral hemorrhage based on cranial CT or MRI and meet the diagnostic criteria;
- Patients are in the non-acute phase, meaning between two weeks and six months after the onset of the disease;
- Patients with limb dysfunction.
You may not qualify if:
- Return to a hospital or rehabilitation facility after discharge;
- The patient has a history of mental illness and dyslexia;
- Patients have a combination of serious, life-threatening conditions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xi Chenlead
- Harbin Medical Universitycollaborator
Study Sites (1)
Daqing Oilfield General Hospital
Daqing, Heilongjiang, 163001, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Due to the nature of the intervention, it is impossible to blind the researcher of the intervention who will deliver the intervention. Therefore, the participants and the outcome assessor will be blinded. The outcome assessor will be blinded to the allocation throughout the study and will independently assess all outcomes at T0, T1, and T2 for both groups.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- researcher
Study Record Dates
First Submitted
May 25, 2024
First Posted
May 31, 2024
Study Start
June 1, 2024
Primary Completion
October 1, 2024
Study Completion
December 1, 2024
Last Updated
September 23, 2024
Record last verified: 2024-09